ESPECIALIZAÇÃO em câncer de mama e câncer do trato gastrointestinal no Dana- Farber Cancer Institute/Harvard Medical School , Boston-MA, EUA.
RESIDÊNCIA MÉDICA: CANCEROLOGIA CLÍNICA no Instituto do Câncer do Estado de São Paulo - HCFMUSP – 2012-2015.
RESIDÊNCIA MÉDICA: Clínica Médica no Hospital das Clínicas da Faculdade de Medicina da USP- 2010-2012.
ENSINO SUPERIOR: Médico formado pela Faculdade de Medicina da Universidade de São Paulo, em julho de 2009.
2019 Palestrante da sessão Manejo de Recorrência local após cirurgia conservadora: mama e axila. Tema: Aspectos do tratamento sistêmico. XXII Congresso Brasileiro de Mastologia 2019 & IX Simpósio Internacional de Mastologia. Rio de Janeiro – Brasil
Exman P, Barroso-Sousa R, Tolaney SM. Evidence to date: talazoparib in the treatment of breast cancer. Onco Targets Ther. 2019 Jul 2;12:5177-5187. doi: 10.2147/OTT.S184971.
Exman P, Mallery RM, Lin NU, Parsons HA. Response to Olaparib in a Patient with Germline BRCA2 Mutation and Breast Cancer Leptomeningeal Carcinomatosis. NPJ Breast Cancer. 2019 Nov 29;5:46. doi: 10.1038/s41523-019-0139-1.
Barroso-Sousa R, Keenan TE, Pernas S, Exman P, Jain E, Garrido-Castro AC, Hughes M, Bychkovsky B, Umeton R, Files JL, Lindeman NI, MacConaill LE, Hodi FS, Krop IE, Dillon D, Winer EP, Wagle N, Lin NU, Mittendorf EA, Van Allen EM, Tolaney SM. Tumor Mutational Burden and PTEN Alterations as Molecular Correlates of Response to PD-1/L1 Blockade in Metastatic Triple-Negative Breast Cancer. Clin Cancer Res. 2020 Jun 1;26(11):2565-2572. doi: 10.1158/1078-0432
Parsons HA, Rhoades J, Reed SC, Gydush G, Ram P, Exman P, Xiong K, Lo CC, Li T, Fleharty M, Kirkner GJ, Rotem D, Cohen O, Yu F, Fitarelli-Kiehl M, Leong KW, Hughes ME, Rosenberg SM, Collins LC, Miller KD, Blumenstiel B, Trippa L, Cibulskis C, Neuberg DS, DeFelice M, Freeman SS, Lennon NJ, Wagle N, Ha G, Stover DG, Choudhury AD, Getz G, Winer EP, Meyerson M, Lin NU, Krop I, Love JC, Makrigiorgos GM, Partridge AH, Mayer EL, Golub TR, Adalsteinsson VA. Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast Cancer. Clin Cancer Res. 2020 Jun 1;26(11):2556-2564. doi: 10.1158/1078-0432.
Mao P, Cohen O, Kowalski KJ, Kusiel JG, Buendia-Buendia JE, Cuoco MS, Exman P, Wander SA, Waks AG, Nayar U, Chung J, Freeman S, Rozenblatt-Rosen O, Miller VA, Piccioni F, Root DE, Regev A, Winer EP, Lin NU, Wagle N. Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER+ Metastatic Breast Cancer. Clin Cancer Res. 2020 Nov 15;26(22):5974-5989. doi: 10.1158/1078-0432
Exman P, Garrido-Castro AC, Hughes ME, Freedman RA, Li T, Trippa L, Bychkovsky BL, Barroso-Sousa R, Di Lascio S, Mackichan C, Lloyd MR, Krevalin M, Cerami E, Merrill MS, Santiago R, Crowley L, Kuhnly N, Files J, Lindeman NI, MacConaill LE, Kumari P, Tolaney SM, Krop IE, Bose R, Johnson BE, Ma CX, Dillon DA, Winer EP, Wagle N, Lin NU. Identifying ERBB2 Activating Mutations in HER2-Negative Breast Cancer: Clinical Impact of Institute-Wide Genomic Testing and Enrollment in Matched Therapy Trials. JCO Precis Oncol. 2019 Nov 15;3:PO.19.00087. doi: 10.1200/PO.19.00087
Freret TS, Exman P, Mayer EL, Little SE, Economy KE. Birthweight and Chemotherapy Exposure in Women Diagnosed with Breast Cancer during Pregnancy. Am J Perinatol. 2020 Sep 24. doi: 10.1055/s-0040-1717075
Exman P, Tolaney SM. HER2-positive metastatic breast cancer: a comprehensive review. Clin Adv Hematol Oncol. 2021 Jan;19(1):40-50. PMID: 33493147.
How We Treat Locally Advanced HER2-Positive Breast Cancer. Clinical Advances. Pedro Exman, MD, Sonia Pernas, MD, PhD, and Sara M. Tolaney, MD, MPH. Hematology & Oncology Volume 17, Issue 5 May 2019
Cancer During Pregnancy: The Oncologist Overview.Hepner A, Negrini D, Hase EA, Exman P, Testa L, Trinconi AF, Filassi JR, Francisco RPV, Zugaib M, O'Connor TL, Martin MG.World J Oncol. 2019 Feb;10(1):28-34
Abemaciclib for treatment of HR+/HER2- breast cancer. Pedro Exman, Sara M. Tolaney. Expert Review of Precision Medicine and Drug Development. 2018 Apr. https://doi.org/10.1080/23808993.2018.1465341
How Old is Too Old? Breast Cancer Treatment in Octogenarians. Exman P, Burstein HJ. Ann Surg Oncol. 2018 Jun;25(6):1458-1460.
De-escalating treatment in the adjuvant setting in HER2-positive breast cancer. Barroso-Sousa R, Exman P, Tolaney SM. Future Oncol. 2018 Apr;14(10):937-945.
Breast cancer-specific survival by age: Worse outcomes for the oldest patients. Freedman RA, Keating NL, Lin NU, Winer EP, Vaz-Luis I, Lii J, Exman P, Barry WT. Cancer. 2018 May 15;124(10):2184-2191
Simultaneous transmission of adenocarcinoma after kidney transplantation. Report of two rare cases. Pedro Exman, Sibele Inacio Meireles, Renata Couldry, Elias David Neto, Jorge Sabbaga. Braz J Oncol. 2017; 13(45):1-7
Primary ovary choriocarcinoma: individual DNA polymorphic analysis as a strategy to confirm diagnosis and treatment. Exman P, Takahashi TK, Gattás GF, Cantagalli VD, Anton C, Nalesso F, Diz Mdel P Rare Tumors. 2013 Jun 13; 5(2): 89-92.
2018: Pedro Exman, Ana Garrido-Castro, Melissa E Hughes, et al. Identifying ERBB-2 activating mutations (mts) in HER2 negative tumors for clinical trials – Impact of institute-wide genomic testing and trial matching on trial enrollment in clinical practice. 2018, San Antonio Breast Cancer Symposium ® Publication Number: P4-04-02.
2018: Pedro Exman, Taylor S Freret, Katherine E Economy, Wendy Y Chen, Heather Ann Parsons, Nancy U Lin, Beverly Moy, Nadine M Tung, Ann H Partridge1and Erica L Mayer. Outcomes and safety of modern chemotherapy schemes in breast câncer and granulocyte-colony stimulating factor (GCSF) in breast cancer in pregnancy (BCP) - A multi-institutional retrospective analysis. 2018, San Antonio Breast Cancer Symposium ® Publication Number: P1-17-02
2013: D Marques, IA Santana, P Exman, GL Palma, D Callegaro Filho, LVM Loureiro, F Emori, SMF Malheiros, MRT Garcia, O Feher. Evaluation Of Perfusion And Apparent Difusion Coefficient (ADC) Evaluated Before And After Chemoradiotherapy (CRT) In Patients (Pts) With Glioblastoma Multiforme (GBM): Is It Helpful? EORTC, EANO, ESMO Conference 2013 (#184) 3/2013.
2013: Exman P, Marques D, Santana IA, Palma GL, Callegaro D, Ayres AS, Garcia MRT, Hoff PM, Feher O. Early Magnetic Ressonance Image (MRI) assessment of diffusion and perfusion in patients (pts) with glioblastoma multiforme (GBM) following chemoradiotherapy (CRT). Is it prognostic? ECCO- ESMO-ESTRO 2013 Amsterdam (#3320) 9/2013.
2012: Exman P, Fonseca LG, Takahashi TK, Medeiros RSS, Saragiotto DF. Sarcoma Histiocitário. Relato de caso raro e revisão de literatura. XIX Congresso Brasileiro de Cancerologia, Fortaleza, Brasil CONCAN 2012.
2012: Exman P, Alves MFS, Camargo VP, Hoff PM. Efeitos adversos da Ifosfamida. Relatos de casos e Revisão de Literatura. Congresso Brasileiro de Cancerologia Fortaleza, Brasil, CONCAN 2012.
Exman P, Mak M, Takahashi TK, Diz MP. Cancêr de Colo Uterino – MANUAL DO RESIDENTE DE CLÍNICA MÉDICA. Editora Manole, 2015.
Exman P, Mak M, Camargo VP. Sarcomas MANUAL DO RESIDENTE DE CLÍNICA MÉDICA. Editora Manole, 2015.
Exman P, Mak M, Camargo VP. Câncer de Pele. MANUAL DO RESIDENTE DE CLÍNICA MÉDICA. Editora Manole, 2015.